Reta 10 mg Kit (10 Vials) Ready to Ship
$110.00
R10 (Retatrutide) — Ready to Ship
R10 is a next-generation triple-agonist research peptide studied for its simultaneous engagement of GLP-1, GIP, and glucagon receptor pathways. One of the most anticipated compounds we’ve brought to the community.
Full Kits Only
Janoshik Tested (Test Pending – will be posted as soon as results are finalized)
For research purposes only. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
In stock
Description
R10 (Retatrutide) is a next-generation triple-agonist research peptide that has become one of the most talked-about compounds in the space. Designed to engage three key metabolic receptor pathways simultaneously — GLP-1, GIP, and glucagon — R10 has generated significant interest in research communities studying metabolic regulation, energy balance, and body composition.
🔬 Key Research Areas
- Triple-Receptor Activation — R20 engages GLP-1R, GIPR, and GCGR receptors simultaneously, making it a uniquely multi-pathway compound in current metabolic research
- Metabolic Regulation — Studied in models exploring glucose metabolism, appetite signaling, and energy expenditure
- Body Composition Research — Among the most researched next-generation peptides for fat metabolism and weight regulation models
- Energy Balance Modeling — Researchers investigate how coordinated receptor activation influences overall systemic energy balance
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. For research purposes only.
